5) Ophthalmic industry mergers/acquisitions continue
As predicted by my previous article in December 2016 (please see Dr. Mali's top 5 predictions in ophthalmology for 2017)2, ophthalmic industry mergers and acquisitions are increasing at a rapid rate; 2017 has already seen such industry maneuvers such as Johnson & Johnson's acquisition of TearScience, Inotek Pharmaceuticals entering into a definitive merger agreement with Rocket Pharmaceuticals, and Luxottica Group (maker of Ray-Ban sunglasses) merging with French optical-lens maker Essilor International, just to name a few of these industry collaborations.
I would not be surprised to see a few more of these types of deals before the end of 2017.
So far, 2017 has been a very exciting year for both ophthalmology and healthcare as a whole. We still have a few months left for more excitement, so stay tuned!
2. Mali, Joshua. Dr. Mali's top 5 predictions in ophthalmology for 2017. Ophthalmology Times. December 24, 2016.